Lataa...
Pharmacokinetics of Anidulafungin in Obese and Normal-Weight Adults
In 2025, approximately one out of five adults will be obese. Physiological changes associated with obesity have been shown to influence the pharmacokinetics of drugs. Anidulafungin is frequently used in critically ill patients, and to achieve optimal efficacy, it is essential that its dose is approp...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6021625/ https://ncbi.nlm.nih.gov/pubmed/29712664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00063-18 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|